14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $14.00 $25.47 Thursday, 2nd May 2024 DCPH stock ended at $25.38. This is 0.0789% more than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 0.493% from a day low at $25.35 to a day high of $25.47.
90 days $13.86 $25.47
52 weeks $9.90 $25.47

Historical Deciphera Pharmaceuticals Inc prices

Date Open High Low Close Volume
Nov 15, 2017 $17.50 $18.35 $16.89 $17.85 129 600
Nov 14, 2017 $17.01 $18.05 $16.93 $17.51 131 200
Nov 13, 2017 $17.25 $18.01 $16.79 $17.67 111 700
Nov 10, 2017 $16.58 $17.51 $16.20 $17.40 155 800
Nov 09, 2017 $16.99 $17.00 $16.47 $16.73 170 100
Nov 08, 2017 $17.76 $17.76 $16.76 $17.00 284 000
Nov 07, 2017 $18.86 $18.86 $17.50 $18.05 77 500
Nov 06, 2017 $19.31 $19.31 $18.38 $18.96 229 700
Nov 03, 2017 $17.88 $19.22 $17.51 $19.01 118 500
Nov 02, 2017 $18.85 $19.32 $17.32 $17.96 211 400
Nov 01, 2017 $19.23 $19.85 $17.36 $19.08 141 300
Oct 31, 2017 $18.94 $19.43 $18.84 $19.19 94 800
Oct 30, 2017 $18.65 $19.59 $18.60 $19.09 387 900
Oct 27, 2017 $19.64 $19.82 $18.03 $18.64 272 000
Oct 26, 2017 $19.53 $19.72 $18.95 $19.40 133 500
Oct 25, 2017 $20.40 $20.40 $18.57 $19.32 118 400
Oct 24, 2017 $20.97 $21.40 $19.50 $20.35 118 700
Oct 23, 2017 $20.94 $22.45 $20.12 $20.79 282 500
Oct 20, 2017 $19.37 $20.79 $19.04 $20.15 139 300
Oct 19, 2017 $19.93 $20.00 $18.80 $19.84 102 900
Oct 18, 2017 $21.38 $22.40 $19.29 $19.96 141 200
Oct 17, 2017 $23.76 $23.90 $21.03 $21.43 181 800
Oct 16, 2017 $24.01 $24.50 $23.31 $24.00 216 300
Oct 13, 2017 $22.72 $24.30 $22.56 $24.20 340 900
Oct 12, 2017 $22.29 $23.00 $21.87 $22.88 181 900
Click to get the best stock tips daily for free!

About Deciphera Pharmaceuticals Inc

Deciphera Pharmaceuticals Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gastrointestinal stromal tumors (GIST), as well as in INTRIGUE Phase 3 study to treat second-line GIST. Th... DCPH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT